Fujifilm completes acquisition of Atara’s cell therapy manufacturing site near Los Angeles

In January, Atara Biotherapeutics inked a deal with Fujifilm Diosynth to exchange its California manufacturing site for $100 million upfront, and a long-term licensing deal for its allogeneic T-cell therapy platform for patients with cancer and autoimmune disease. Monday, the biotech announced that the deal has...

Click to view original post